{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:gozanertinib [INN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02443155: Phase 2 Interventional Completed Diabetes
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02298946: Phase 1 Interventional Completed Colorectal Cancer
(2014)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02531178: Phase 1 Interventional Completed Rheumatoid Arthritis
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02848911: Phase 1 Interventional Terminated Leukemia, B-Cell
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03338556: Phase 2 Interventional Completed Viral Upper Respiratory Tract Infection
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03739996: Phase 2 Interventional Completed HIV Infections
(2019)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02028403: Phase 1 Interventional Completed HIV Infections
(2014)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02040506: Phase 1 Interventional Completed Acute Myelogenous Leukemia
(2014)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02262455: Phase 1 Interventional Completed Ovarian Cancer
(2014)
Source URL:
Class:
CONCEPT